Creso Pharma's Mernova enters Canada’s largest recreational cannabis market
Finfeed
Archived
Feb 17, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,199).